Dirac technology included in Emotiva devices
The LXR-11 and LXP-16 feature Dirac Live Room Correction, Bass Control, and Active Room Treatment as standard without extra costs.
Latest Dirac News & Updates
See the latest news and media coverage for Dirac. We track all announcements, press releases, and industry mentions in real time, all in one place.
Last updated
Latest news about Dirac
In short: Dirac expanded automotive and room-correction audio, launching Dirac Spaces with NIO and a PC/Mac processor.
Company announcements
Dirac introduces Live Active Room Treatment
This technology controls bass resonances to improve clarity and consistency across the listening area using coordinated speaker output.
Dirac names Anders Storm CEO
He brings thirty years of software and semiconductor leadership and joins as Dirac pursues growth amid record automotive and home audio sales.
Dirac raises $17.73 million in direct share issue
TIN Fonder and DIG Investment each invested $8.9M, valuing Dirac at about $142.2M and supporting international growth and software-driven audio expansion.
Media coverage
Dirac debuts software-defined in-car audio with NIO ES9
Dirac has launched its 'Dirac Spaces' platform with NIO, debuting in the ES9 SUV alongside the Lyra sound system. The software models and replicates the...
Dirac launches Dirac Spaces for immersive in‑car audio experiences
Dirac Spaces is an automotive audio solution that recreates the acoustic characteristics of real‑world environments.
Never miss news about Dirac
Track Dirac and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
SharkNinja
NRx
Ropes & Gray
HighTech Kaunas
inretrn
Poundland
Farrer & Co
Specialfastigheter
SISAB
Hemsö
Stenvalvet
Liljewall
Veidekke
Locum
NCC
Kriminalvården
Archus
Nyréns
Peab
MVB
VGR fastigheter
AIX
ByggDialog
Tengbom
LINK
Dynacon
Delphidata
Waystream
Netnod
Open Infra
PENN Entertainment
BrandCrowd
Itancia
Paul, Weiss
Prime Medicine
AN2 Therapeutics